Andrei Gafita
@DrAGafita
Followers
360
Following
365
Statuses
79
Johns Hopkins Medicine | Prostate Cancer Theranostics | @JHtheranostics l All views are my own
Baltimore, MD
Joined October 2020
Delighted to see RECIP 1.0: Response Evaluation Criteria In PSMA-Imaging for men with mCRPC published in @JournalofNucMed. International collaborative work @ProfHadaschik @CalaisJeremie @CzerninJohannes supported by @PCF_Science. #RECIP #PSMA
0
5
15
0
0
3
Congratulations to our fantastic team at Johns Hopkins Theranostics Center for being recognized by @SNM_MI a Therapy Center of Excellence! @liljasolnes @AveryS32342 @daniellerill Jeffrey Young @Hopkins_Rad
The JHH theranostics team was recently recognized by @SNM_MI as a Radiopharmaceutical Therapy Center of Excellence! The designation aims to ensure patient access to high-quality radiopharmaceutical therapy. Congratulations to our theranostics team for a well-deserved honor!
0
2
5
0
0
0
@RECIP_criteria validated on end-of-treatment PSMA-PET/CT scan performed after 177Lu-PSMA-617. @JournalofNucMed #RECIP
Prognostic value of end-of-treatment PSMA PET/CT in patients treated with 177Lu-PSMA radioligand therapy: a retrospective, single-center analysis. #BeyondTheAbstract with @VMurthymed @dgsomucla > @JournalofNucMed @CalaisJeremie @CzerninJohannes @DrAGafita
0
0
1
@brookmans76 @CalaisJeremie @DrMHofman @PCFnews @TheLancetOncol @drlouiseemmett @ButeauJames @SandhuShahneen @DrAIravani @brookmans76 these models include SUVmean as a continous variable along with clinical parameters.
0
0
1
@PGrivasMDPhD @JessicaHawleyMD @OncoAlert @urotoday @Uromigos Thanks Jess and Petros! Great team effort from RECIP Investigators @Wolfgang Fendler @CalaisJeremie @ProfHadaschik @ProfKHerrmann @andrea_farolfi @DjailebLoic @MatthiasEiber @Rowe_NuclearMed and an invaluable support from @PCF_Science
0
2
9
RT @Rowe_NuclearMed: 100 years of the fundamental principle of #nuclearmedicine and #molecularimaging. @DrAGafita @…
0
2
0
@Rowe_NuclearMed @SNM_MI @JournalofNucMed Thank you @Rowe_NuclearMed for your mentorship and incredible input on this project!
0
1
1
Superb work using AI for automatic treatment response evaluation in prostate cancer. #RECIP validated in early stage prostate cancer in patients with BCR and low tumor burden.
0
1
7
RT @Rowe_NuclearMed: Excellent work by @liljasolnes and her team @HopkinsMedicine to explore imaging biomarkers of neurodegenerative diseas…
0
2
0
RT @DrMHofman: 🌟Introducing PROMISE 2 for standardized evaluation of PSMA PET/CT! 📄Unlock the full potential for clinical routine & researc…
0
35
0
@AnnetteVDHeyden Always a pleasure to catch up with great friends & collaborators @AnnetteVDHeyden @ButeauJames @liz_medhurst @Shae_Collins_
0
0
6
So grateful to visit @DrMHofman and the amazing team at @PeterMacCC Nuclear Medicine. @PCF_Science @soulehoward1. Unique collaboration of @HopkinsNucs!
Great collage of an amazing day. Such a pleasure to have @PCF_Science visit @PeterMacCC. Incredible team science 👇
0
3
16
@JessicaHawleyMD @DeptofDefense @cncrfghtr_drake @PGrivasMDPhD @UWMedicine @uwurology @Prostate_IPCR Congrats Jessica! You’re making history with those scores 🤣
1
1
2
@officialEANM highlights that radiopharmaceutical therapy has a long history as a therapeutic delivered by nuclear medicine specialists. @ProfKHerrmann
0
1
4
@coronilRMD @JournalofNucMed @PCF_Science We used qPSMA - SUV threshold -> 3 for bone mets and liver-based threshold for soft-tissue lesions. But any tumor segmentation software can be used. Important just to use same software and same segmentation method for baseline and followup scans.
1
0
1